Oct 22, 2024 4:06 AM
BACK TO TOP
KSE100
86,057.51
807.42
(0.95%)
ALLSHR
55,449.98
522.74
(0.95%)
KSE30
27,044.31
241.27
(0.90%)
KMI30
130,892.66
1623.68
(1.26%)
BKTI
21,646.38
83.32
(0.39%)
OGTI
21,157.05
97.29
(0.46%)
KMIALLSHR
38,001.58
528.21
(1.41%)
PSXDIV20
34,336.76
310.96
(0.91%)
UPP9
26,002.30
168.29
(0.65%)
NITPGI
20,832.55
114.43
(0.55%)
NBPPGI
23,245.20
155.62
(0.67%)
MZNPI
17,141.59
183.85
(1.08%)
JSMFI
23,995.79
222.62
(0.94%)
ACI
12,969.79
181.76
(1.42%)
JSGBKTI
23,609.37
71.74
(0.30%)
MII30
12,099.67
162.76
(1.36%)
HBLTTI
15,058.22
18-10-2024
8.04
(0.05%)
Highnoon Laboratories Limited
PHARMACEUTICALS
Rs.776.00
6.53
(0.85%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Oct 21, 2024 4:09 PM
REG
FUT
ODL
Open
769.62
High
783.00
Low
769.00
Volume
109,066
CIRCUIT BREAKER
692.52 — 846.42
DAY RANGE
769.00 — 783.00
52-WEEK RANGE
412.00 — 840.93
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
769.47
VAR
10.00
HAIRCUT
22.50
P/E Ratio (TTM) **
15.21
1-Year Change *
86.88%
YTD Change *
53.80%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Highnoon Laboratories Limited (“the Company”) was incorporated in Pakistan under the repealed Companies Ordinance 1984 (now Companies Act, 2017) (“the Act”) and its shares are quoted on Pakistan Stock Exchange since November 1994. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and related consumer products. The registered office of the Company is situated at 17.5 km, Multan Road, Lahore.

KEY PEOPLE
Dr. Adeel Abbas HaideriCEO
Tausif Ahmad KhanChairperson
Baqar HasanCompany Secretary
ADDRESS

17.5 Kilometer Multan Road, Lahore

WEBSITE

www.highnoon-labs.com

REGISTRAR

Corplink (Pvt.) Ltd. Wings Arcade, 1-K Commercial, Model Town, Lahore.

AUDITOR

M/s BDO Ebrahim & Co. Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
41,115,093.57
Shares
52,983,368
Free Float
21,193,345
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Aug 29, 2024Transmission of Quarterly Report for the Period Ended 2024-06-30 View   PDF
Aug 29, 2024Financial Results for the Quarter Ended 2024-06-30 View   PDF
Apr 29, 2024Transmission of Quarterly Report for the period ended 31 March 2024 View   PDF
Apr 29, 2024Financial Results for the 1st Quarter ended 31 March 2024 View   PDF
Apr 9, 2024Transmission of Annual Report for the year ended 31 December 2023 View   PDF
Mar 29, 2024Financial Results for the year ended 31 December 2023 View   PDF
Oct 30, 2023Transmission of Quarterly Report for the period ended 30 September 2023 View   PDF
Oct 30, 2023Financial Results for the Quarter ended 30 September 2023 View   PDF
Sep 4, 2023Tranmission of Quarterly Report for the period ended 30 June 2023 View   PDF
Aug 17, 2023Financial Results for the Quarter ended 30 June 2023 View   PDF
DateTitleDocument
Oct 21, 2024Board Meeting View   PDF
Aug 22, 2024Board Meeting View   PDF
Aug 12, 2024Notice of Extraordinary General Meeting View   PDF
Jul 8, 2024Board Meeting Other than Financial Results View   
May 2, 2024Extract of Resolutions Passed at the 41st Annual General Meeting View   PDF
Apr 23, 2024Board Meeting View   
Apr 8, 2024Notice of Annual General Meeting View   PDF
Mar 28, 2024Board Meeting in Progress View   
Mar 21, 2024Board Meeting View   
Jan 9, 2024Board Meeting other than Financial Results View   
Oct 23, 2023Board Meeting View   
DateTitleDocument
Sep 9, 2024Re Appointment of the Chairman and Chief Executive Officer View   PDF
Sep 2, 2024Election of Directors View   PDF
Aug 26, 2024Notice Election of Directors View   PDF
Aug 1, 2024Material Information View   PDF
Jul 22, 2024Company Secretary View   
Jul 18, 2024Fixation of Number of Directors View   PDF
May 16, 2024Material Information View   PDF
May 14, 2024Dispatch of Final Divident Warrants View   
May 8, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
May 6, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2023202220212020
Sales19,424,25515,815,93713,000,78010,697,634
Profit after Taxation2,403,0142,417,1721,808,0331,420,736
EPS45.3545.6243.1741.04
Q2 2024Q1 2024Q3 2023Q2 2023
Sales5,417,4655,614,2205,080,7144,942,469
Profit after Taxation738,331763,120618,772576,117
EPS13.9414.4011.6810.87
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2023202220212020
Gross Profit Margin (%)47.6450.7749.3547.87
Net Profit Margin (%)12.3715.2813.9113.28
EPS Growth (%)(0.59)5.685.1946.31
PEG(18.80)2.092.800.32

Payouts

DateFinancial ResultsDetailsBook Closure
March 29, 2024 11:53 AM31/12/2023(YR) 300%(F) (D) 22/04/2024 - 29/04/2024
June 12, 2023 2:59 PM- 15%(I) (B) 20/06/2023 - 22/06/2023
February 23, 2023 2:48 PM31/12/2022(YR) 200%(F) (D) - 10% (B) 22/04/2023 - 29/04/2023
March 16, 2022 3:48 PM31/12/2021(YR) 200% (D) - 10% (B) 11/04/2022 - 18/04/2022
March 25, 2021 4:01 PM31/12/2020(YR) 150%(F) (D) - 10% (B) 26/04/2021 - 27/04/2021
March 31, 2020 3:12 PM31/12/2019(YR) 130% (D) - 10% (B) 05/05/2020 - 12/05/2020
March 29, 2019 4:20 PM31/12/2018(YR) 130%(F) (D) - 10% (B) 23/04/2019 - 29/04/2019
March 9, 2018 3:55 PM31/12/2017(YR) 100% (D) - 12% (B) 12/04/2018 - 23/04/2018
March 16, 2017 3:45 PM31/12/2016(YR) 85% (D) - 12% (B) 21/04/2017 - 27/04/2017
March 15, 2016 3:38 PM31/12/2015(YR) 75% (D) - 12% (B) 14/04/2016 - 22/04/2016

Financial Reports